OOIR: Observatory of International Research

Papers

(The H4-Index of Heart Rhythm is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management	537
COVID-19 and cardiac arrhythmias	311
COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors	206
QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin	194
2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families	156
SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes	148
Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electroc	145
QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review	127
Left bundle branch–optimized cardiac resynchronization therapy (LOT-CRT): Results from an international LBBAP collaborative study group	117
Physiology-based electrocardiographic criteria for left bundle branch capture	112
Clinical outcomes of left bundle branch area pacing compared to right ventricular pacing: Results from the Geisinger-Rush Conduction System Pacing Registry	110
The possible association between COVID-19 and postural tachycardia syndrome	105
Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials	103
Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial	92
Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia	92
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure	90
Cardiac radioablation—A systematic review	89
Clinical outcomes of conduction system pacing compared to biventricular pacing in patients requiring cardiac resynchronization therapy	79
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Gen	79
Intermediate-term performance and safety of His-bundle pacing leads: A single-center experience	78
Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms	76
Marshall bundle elimination, Pulmonary vein isolation, and Line completion for ANatomical ablation of persistent atrial fibrillation (Marshall-PLAN): Prospective, single-center study	74
Left bundle branch pacing compared to left ventricular septal myocardial pacing increases interventricular dyssynchrony but accelerates left ventricular lateral wall depolarization	73
Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection	73
Wearables in cardiology: Here to stay	68

Genetic susceptibility for COVID-19–associated sudden cardiac death in African Americans	65
A new smart wristband equipped with an artificial intelligence algorithm to detect atrial fibrillation	64
Epicardial course of the septopulmonary bundle: Anatomical considerations and clinical implications for roof line completion	64
Off-label dosing of non–vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation	63
Postural orthostatic tachycardia syndrome as a sequela of COVID-19	58
Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations	57
Fixation beats: A novel marker for reaching the left bundle branch area during deep septal lead implantation	56
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients	55
Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study	55
Generalizability of the CASTLE-AF trial: Catheter ablation for patients with atrial fibrillation and heart failure in routine practice	54
Real-world experience of leadless left ventricular endocardial cardiac resynchronization therapy: A multicenter international registry of the WiSE-CRT pacing system	53
Deep learning for comprehensive ECG annotation	52
Catheter ablation of atrial fibrillation using ablation index–guided high power (50 W) for pulmonary vein isolation with or without esophageal temperature probe (the AI-HP ESO II)	51
Acute and long-term results of bipolar radiofrequency catheter ablation of refractory ventricular arrhythmias of deep intramural origin	51
Effects of hydroxychloroquine treatment on QT interval	50
Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: Results from International LBBAP Collaborative Study Group	49
Electrophysiological characteristics of septal perforation during left bundle branch pacing	49
Esophageal temperature dynamics during high-power short-duration posterior wall ablation	48
Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator	47